Skip to main content
U.S. Department of Health & Human Services
National Institutes of Health
NCATS

COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC: https://www.coronavirus.gov (link is external)
Get the latest research information from NIH: https://covid19.nih.gov (link is external)

National Center for Advancing and Translational Sciences National Center for Advancing and Translational Sciences Genetic and Rare Diseases Information Center, a program of the National Center for Advancing and Translational Sciences Genetic and Rare Diseases Information Center, a program of the National Center for Advancing and Translational Sciences
1-888-205-2311
Menu Search
1-888-205-2311
Menu
  • Home
  • Diseases expand submenu for Diseases
    • Browse A-Z
    • Find Diseases By Category expand submenu for Find Diseases By Category
      • Autoimmune / Autoinflammatory diseases
      • Bacterial infections
      • Behavioral and mental disorders
      • Blood Diseases
      • Chromosome Disorders
      • Congenital and Genetic Diseases
      • Connective tissue diseases
      • Digestive Diseases
      • Ear, Nose, and Throat Diseases
      • Endocrine Diseases
      • Environmental Diseases
      • Eye diseases
      • Female Reproductive Diseases
      • Fungal infections
      • Heart Diseases
      • Hereditary Cancer Syndromes
      • Immune System Diseases
      • Kidney and Urinary Diseases
      • Lung Diseases
      • Male Reproductive Diseases
      • Metabolic disorders
      • Mouth Diseases
      • Musculoskeletal Diseases
      • Myelodysplastic Syndromes
      • Nervous System Diseases
      • Newborn Screening
      • Nutritional diseases
      • Parasitic diseases
      • Rare Cancers
      • RDCRN
      • Skin Diseases
      • Viral infections
    • List of FDA Orphan Drugs
    • GARD Information Navigator
    • FAQs About Rare Diseases
  • Guides expand submenu for Guides
    • Patients, Families and Friends expand submenu for Patients, Families and Friends
      • How to Find a Disease Specialist
      • Tips for the Undiagnosed
      • Support for Patients and Families
      • Tips for Finding Financial Aid
      • Help with Travel Costs
      • How to Get Involved in Research
      • FAQs About Chromosome Disorders
      • Medical and Science Glossaries
    • Healthcare Professionals expand submenu for Healthcare Professionals
      • Caring for Your Patient with a Rare Disease
      • ICD Coding for Rare Diseases
      • FindZebra Diagnosis Assist Tool
    • Researchers expand submenu for Researchers
      • Finding Funding Opportunities
    • Teachers and Students expand submenu for Teachers and Students
      • Teaching Resources
  • News expand submenu for News
    • In The Spotlight
    • News Archive
    • Connect with GARD
    • Media Requests
  • About GARD expand submenu for About GARD
    • Contact GARD
    • About GARD
    • Videos
    • Brochures and Publications
  • En Español expand submenu for En Español
    • Enfermedades
    • Contacte GARD
    • Guías de Información expand submenu for Guías de Información
      • Preguntas Más Frecuentes Sobre Enfermedades Raras
      • Como Encontrar un Especialista en su Enfermedad
      • Consejos Para una Condición no Diagnosticada
      • Consejos Para Pacientes y Familias
      • Consejos Para Obtener Ayuda Financiera Para Una Enfermedad
      • Participe en Estudios de Investigación
      • Preguntas Más Frecuentes Sobre los Trastornos Cromosómicos
    • Sobre GARD
  • Home
© Positive Exposure
banner showing people with disabilities and/or their relatives
  1. Home
  2. Diseases
  3. North Carolina macular dystrophy
print
  • Table of Contents expand submenu for Table of Contents
    • Summary
    • Symptoms
    • Cause
    • Find a Specialist
    • Research
    • Learn More
    • News & Events
    • GARD Answers
    • References
  • Browse A-Z
  • Find Diseases By Category expand submenu for Find Diseases By Category
    • Autoimmune / Autoinflammatory diseases
    • Bacterial infections
    • Behavioral and mental disorders
    • Blood Diseases
    • Chromosome Disorders
    • Congenital and Genetic Diseases
    • Connective tissue diseases
    • Digestive Diseases
    • Ear, Nose, and Throat Diseases
    • Endocrine Diseases
    • Environmental Diseases
    • Eye diseases
    • Female Reproductive Diseases
    • Fungal infections
    • Heart Diseases
    • Hereditary Cancer Syndromes
    • Immune System Diseases
    • Kidney and Urinary Diseases
    • Lung Diseases
    • Male Reproductive Diseases
    • Metabolic disorders
    • Mouth Diseases
    • Musculoskeletal Diseases
    • Myelodysplastic Syndromes
    • Nervous System Diseases
    • Newborn Screening
    • Nutritional diseases
    • Parasitic diseases
    • Rare Cancers
    • RDCRN
    • Skin Diseases
    • Viral infections
  • List of FDA Orphan Drugs
  • GARD Information Navigator
  • FAQs About Rare Diseases
You can help advance
rare disease research!
You can help advance rare disease research!
toolbox
Find out how with the NCATS Toolkit.

North Carolina macular dystrophy


Title




Other Names:
NCMD; Macular dystrophy retinal 1 North Carolina type; MCDR1; NCMD; Macular dystrophy retinal 1 North Carolina type; MCDR1; Central areolar pigment epithelial dystrophy; CAPED; Retinal pigment epithelial dystrophy central; Foveal dystrophy progressive See More
Categories:
Congenital and Genetic Diseases; Eye diseases

Summary Summary


Listen
North Carolina macular dystrophy (NCMD) is an inherited eye disorder that affects the development of the macula, the small, but important part of the eye located in the center of the retina. The macula allows a person to see fine details and do tasks that require central vision, such as reading and driving. It is also important for seeing colors. The severity of changes in the development of the macula varies, causing some people to have little or no vision loss, while others may have severe vision loss.[1][2][3][4] NCMD is considered non-progressive, which means most researchers believe the vision loss does not change after birth.[3] Others believe it may progress slowly through age twelve.[14914] However, vision loss may increase if complications develop, such as new, abnormal blood vessels growing under the retina (choroidal neovascularization).[1][2][3][4]

NCMD is caused by changes (mutations) in a region of chromosome 6 (MCDR1 locus), as well as in a region of chromosome 5 (MCDR3 locus).[1][3][4][5] Although there is no cure for NCMD, treatment may include low vision aids such as glasses with high powered lenses, large print reading material, and computer software that can turn text into speech.[5]
Last updated: 12/28/2017

Symptoms Symptoms


Listen
The main symptom of North Carolina macular dystrophy (NCMD) is blurred central vision with normal color vision, although some people do have problems with color vision as well. Vision loss can range from very mild to very severe. Both eyes are usually affected the same. For the most part, vision loss does not get worse over time, although some researchers suggest it may be slowly progressive through age 12.[2][3][4] 

Findings on eye exam also vary and can be classified into three different grades depending on severity of changes that occurred during the development of the macula and related parts of the eye. It is important to remember a person with NCMD is born with these changes, rather than these changes developing throughout a person's lifetime. The Grades may be described as:[2][4]
  • Grade 1: Yellow-white spots or lesions (drusen) on the macula (usually causing no vision loss or mild blurriness of fine details)
  • Grade 2: Clustered and joined yellow-white spots (drusen) on the macula with or without changes within the retinal pigment epithelium (RPE) and formation of scar tissue. The RPE is the colored part of the retina, and although it is not involved in vision, it helps the retinal cells involved in vision get the nourishment needed to stay healthy. 
  • Grade 3: Thin outer, white coat of the eye (staphyloma) or loss of macular tissue (coloboma) with damage and loss of tissue in the layer of nerves and blood vessels under the retina (choroid) and retina (chorioretinal atrophy). Vision loss is usually more severe with these findings. 
New blood vessels may also develop in the choroid (choroidal neovascularization) later in life, although this is not common. The choroid is a layer of nerves and blood vessels under the retina. The retina needs a healthy choroid to work. The abnormal growth of blood vessels in the choroid can damage the retina causing increased vision loss.[2][3][4] 
Last updated: 12/28/2017

This table lists symptoms that people with this disease may have. For most diseases, symptoms will vary from person to person. People with the same disease may not have all the symptoms listed. This information comes from a database called the Human Phenotype Ontology (HPO) . The HPO collects information on symptoms that have been described in medical resources. The HPO is updated regularly. Use the HPO ID to access more in-depth information about a symptom.

Showing of 8 |
Medical Terms Other Names
Learn More:
HPO ID
Percent of people who have these symptoms is not available through HPO
Abnormality of macular pigmentation 0008002
Autosomal dominant inheritance 0000006
Central scotoma
Central blind spot
0000603
Drusen 0011510
Generalized aminoaciduria 0002909
Macular dystrophy 0007754
Peripheral retinal atrophy
Wasting of the outer part of the retina
0200070
Reduced visual acuity
Decreased clarity of vision
0007663
Showing of 8 |
Do you have more information about symptoms of this disease? We want to hear from you.
Last updated: 2/1/2021
Do you have updated information on this disease? We want to hear from you.

Cause Cause


Listen
In most families, North Carolina macular dystrophy (NCMD) is caused by changes in a specific area (locus) of chromosome 6, called the MCDR1 locus. However, other families with NCMD have been found to have changes in the MCDR3 locus on chromosome 5.[1][3][4][5] Genetic changes that cause a disease used to be called mutations, but now are more commonly called pathogenic variations.

The way a pathogenic variation in the genetic locus causes NCMD can be hard to understand. In many genetic diseases, the change in the DNA that causes the disease is in a gene, and in these cases, the pathogenic variation changes the instructions (code) for making the gene's protein. But medical researchers believe the pathogenic variations that cause NCMD are in non-coding areas of the DNA. These regions of the DNA may control when the proteins are made from other nearby genes (gene expression). In fact in 2016, medical researchers found that pathogenic variations in the MCDR1 locus are in non-coding regions close to the PRDM13 gene. The protein made from the PDRM13 gene is believed to be important for macular development. However, it is too early to tell if the pathogenic variations in the MCDR1 locus are changing the expression of the PRDM13 gene.[5] Similarly, studies in 2017 suggest the MCDR3 locus is also involved in controlling when other genes are turned on (gene expression). At present researches believe the changes in the MCDR3 locus that cause NCMD may be affecting the expression of the IRX1 gene. But again it is too early to be certain.[3]
Last updated: 12/28/2017

Find a Specialist Find a Specialist


Listen

If you need medical advice, you can look for doctors or other healthcare professionals who have experience with this disease. You may find these specialists through advocacy organizations, clinical trials, or articles published in medical journals. You may also want to contact a university or tertiary medical center in your area, because these centers tend to see more complex cases and have the latest technology and treatments.

If you can’t find a specialist in your local area, try contacting national or international specialists. They may be able to refer you to someone they know through conferences or research efforts. Some specialists may be willing to consult with you or your local doctors over the phone or by email if you can't travel to them for care.

You can find more tips in our guide, How to Find a Disease Specialist. We also encourage you to explore the rest of this page to find resources that can help you find specialists.

Healthcare Resources

  • To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the American College of Medical Genetics and the National Society of Genetic Counselors. If you need additional help, contact a GARD Information Specialist. You can also learn more about genetic consultations from MedlinePlus Genetics.

Research Research


Listen

Research helps us better understand diseases and can lead to advances in diagnosis and treatment. This section provides resources to help you learn about medical research and ways to get involved.

Clinical Research Resources

  • The Centers for Mendelian Genomics program is working to discover the causes of rare genetic disorders. For more information about applying to the research study, please visit their website.

Learn More Learn More


Listen

These resources provide more information about this condition or associated symptoms. The in-depth resources contain medical and scientific language that may be hard to understand. You may want to review these resources with a medical professional.

In-Depth Information

  • The Monarch Initiative brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch’s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.
  • Online Mendelian Inheritance in Man (OMIM) is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine. 
  • Orphanet is a European reference portal for information on rare diseases and orphan drugs. Access to this database is free of charge.
  • PubMed is a searchable database of medical literature and lists journal articles that discuss North Carolina macular dystrophy. Click on the link to view a sample search on this topic.

News & Events News & Events


Listen

News

  • Rare Disease Day at NIH 2021
    March 1, 2021

GARD Answers GARD Answers


Listen

Questions sent to GARD may be posted here if the information could be helpful to others. We remove all identifying information when posting a question to protect your privacy. If you do not want your question posted, please let us know.

Have a question? Contact a GARD Information Specialist.

References References


  1. Macular Dystrophy, Retinal, 1, North Carolina Type; MCDR1. Online Mendelian Inheritance in Man (OMIM). August 11, 2016; http://www.omim.org/entry/136550.
  2. Khurana RN, Sun X, Pearson E, Yang Z, Harmon J, Goldberg MF, Zhang K. A Reappraisal of the Clinical Spectrum of North Carolina Macular Dystrophy. Ophthalmology. October 2009; 116(10):1976-1983. https://www.ncbi.nlm.nih.gov/pubmed/19616854.
  3. Cipriani V, Silva RS, Arno G, et al. Duplication events downstream of IRX1 cause North Carolina macular dystrophy at the MCDR3 locus. Scientific Reports. August 8, 2017; 7(1):7512-18. https://www.mcbi.nlm.nih.gov/pmc/articles/PMC5548758/.
  4. Audere M, Rutka K, Inaskina I, Peculis R, Sepetiene S, Valeina S, Lace B. Genetic linkage studies of a North Carolina macular dystrophy family. Medicina (Kaunas). 2016; 52(3):180-6. https://www.ncbi.nlm.nih.gov/pubmed/27496188.
  5. Small KW, DeLuca AP, Whitmore SS, et al. North Carolina Macular Dystrophy Is Caused by Dysregulation of the Retinal Transcription Factor PRDM13. Ophthalmology. January 2016; 123(1):9-28. https://www.ncbi.nlm.nih.gov/pubmed/26507665.
Do you know of a review article? We want to hear from you.
You can help advance
rare disease research!
You can help advance rare disease research!
toolbox
Find out how with the NCATS Toolkit.

Share this content:

Share this content:

twitter-icon facebook-icon contact-icon link-icons

Copy Link

Link copied to your clipboard.

printer-icon

You May Be Interested In

How to Find a Disease Specialist

How to Find a Disease Specialist

Tips for the Undiagnosed

Tips for the Undiagnosed

Support for Patients and Families

Support for Patients and Families

Tips for Finding Financial Aid

Tips for Finding Financial Aid

Help with Travel Costs

Help with Travel Costs

How to Get Involved in Research

How to Get Involved in Research

FAQs About Chromosome Disorders

FAQs About Chromosome Disorders

Medical and Science Glossaries

Medical and Science Glossaries

Caring for Your Patient with a Rare Disease

Caring for Your Patient with a Rare Disease

ICD Coding for Rare Diseases

ICD Coding for Rare Diseases

FindZebra Diagnosis Assist Tool

FindZebra Diagnosis Assist Tool

Finding Funding Opportunities

Finding Funding Opportunities

Teaching Resources

Teaching Resources

placeholder for the horizontal scroll slider Back to top
GARD Home NCATS Home Site Map Browse Glossary A-Z Privacy Notice Disclaimer Accessibility FOIA OIG

If you have problems viewing PDF files, download the latest version of Adobe Reader

For language access assistance, contact the NCATS Public Information Officer

Genetic and Rare Diseases Information Center (GARD) - PO Box 8126, Gaithersburg, MD 20898-8126 - Toll-free: 1-888-205-2311

contact gard Office of Rare Disease Research Facebook Page Office of Rare Disease Research on Twitter
Listen